Media City
  • Explore
    • The FBS problem
    • Explore FRS Pioneer
  • Products
    • FRS Pioneer
    • GECKO
    • Support Services
  • Resources
    • Data & Application Notes
    • Frequently asked questions
  • Connect
    • Request a Quote
    • Contact
    • Updates
  • About

Frequently asked questions (FAQs)

​Does FRS Pioneer support the growth of a wide range of cell types?
FRS Pioneer is a broad-spectrum, chemically defined replacement for fetal bovine serum designed for routine cell culture. It is designed to support a broad range of standard immortalised cell lines.
Performance depends on cell type, basal medium, surface preparation, and culture conditions. Please refer to application notes and data sheets for cell-specific examples and experimental context.
​Does FRS Pioneer vary between batches?
No. FRS Pioneer is manufactured using defined components and controlled specifications, resulting in consistent composition between batches.
Each production lot is equivalent to previous lots, supporting reproducibility within and between laboratories over time.
​Does FRS Pioneer contain any animal-derived components?
No. FRS Pioneer is chemically defined and free from animal-derived components. This avoids many sources of biological variability and trace contaminants associated with serum.
Is FRS Pioneer suitable for clinical or GMP use?
FRS Pioneer is a research-use product and is not supplied as a clinical or GMP-grade material.
Media City Scientific can support discussions around cGMP-aligned FRS formulations where required for downstream applications.
​Will it be difficult to adapt my cells from FBS to FRS Pioneer?
For many systems, FRS Pioneer successfully supports direct adaptation from fetal bovine serum, without requiring extended multi-step or sequential adaptation protocols.
However, adaptation outcomes ultimately depend on the specific cell line, basal medium, and culture setup. Some cell lines may benefit from a sequential adaptation protocol. We recommend monitoring growth and morphology during transition and optimising surface preparation for adherent cells as needed.
​Does FRS Pioneer support adherent cells?
Yes, but adhesion is handled separately by design.
FRS Pioneer does not include adhesion factors present in serum. For adherent cells, appropriate surface preparation is required, which may include:
  • Coating plates with serum-containing media
  • Cell-type-specific coatings (e.g. gelatin, fibronectin, vitronectin, Matrigel)
  • Broad-spectrum, chemically defined, animal-free coatings (e.g. GECKO by Media City Scientific)
Surface choice can influence attachment efficiency and achievable cell density.
​Is there anything present in FBS that is not present in FRS Pioneer?
Yes. Fetal bovine serum contains a wide range of immune signalling proteins and molecules, including complement proteins, immunoglobulins, and many cytokines. These components are not present in FRS Pioneer. Their absence can reduce background signal in downstream assays.

FBS also contains adhesion-associated factors that are not included in FRS Pioneer. This can be advantageous when adapting adherent cells to suspension culture and for other studies which require precise control of adhesion.
Is FRS Pioneer a drop-in replacement for FBS in all systems?
No. While FRS Pioneer is designed for broad compatibility and has been validated for a broad range of immortalised cell lines, it is not a guaranteed replacement for FBS in every cell type or application.
Performance depends on experimental context, and some systems may require optimisation or alternative formulations.
Is FRS Pioneer optimised for high-density culture?
No. FRS Pioneer is not positioned as a high-density, cell specific biomass-maximisation medium. It is intended for cell culture where control, consistency, and reduced variability are priorities.
How much does FRS Pioneer cost?
FRS Pioneer is priced on par with premium fetal bovine serum. Current pricing is listed on the products page.
Can FRS Pioneer be used as a freeze medium?
Yes. FRS Pioneer is compatible with DMSO and has been validated as a freezing medium for many cell types. As with growth applications, freeze–thaw performance should be validated for each cell line.
Have you completed transcriptomic (e.g. RNA-seq) comparisons between FRS and FBS?
​We have not yet completed broad, untargeted transcriptomic comparisons between FRS and FBS across cell lines. To date, we have prioritised functional testing as the primary way to assess whether the supplement affects cell behaviour.
Some level of transcriptional variation is expected in routine cell culture, including differences introduced by:
  • FBS lot-to-lot variability
  • basal media formulation
  • antibiotic use
  • thawing, passaging, and media changes
These effects are readily detectable at the transcriptional level, even when they do not translate into meaningful differences in cell behaviour or assay performance and are widely tolerated in serum-based culture when functional performance is acceptable.
FRS is designed to provide a consistent, chemically defined alternative to FBS, reducing long-term variability rather than attempting to replicate the shifting composition of individual FBS lots. As with any media choice, the relevance of transcriptomic differences depends on the biological question being asked.
Why prioritise functional testing over transcriptomics?
Our primary focus has been on functional equivalence and usability, including:
  • direct adaptation from FBS to FRS without observable impacts on proliferation, morphology, or downstream differentiation capability, where tested
  • conserved functional readouts, including intracellular cAMP signalling and maintained transfection performance in HEK cells
  • absence of overt stress phenotypes or adaptation artefacts across a broad range of cells.
This suggests that any transient transcriptional responses associated with adaptation fall within the normal background stress routinely tolerated in standard in vitro culture, rather than indicating a pathological or unstable baseline state.
When would gene expression analysis matter?
Transcriptomic analysis is most informative when transcriptional state is itself part of the assay risk, such as:
  • pathway-dependent or biomarker-driven readouts,
  • differentiation or fate-mapping studies,
  • stress- or transcription factor–sensitive systems.
In these cases, media choice can matter, and targeted validation may be appropriate or critical.
​Where can I find validation data?
Application notes, data sheets, and example datasets are available on the website and will be updated as additional evaluations are completed. Please reach out directly if you have specific questions about your system; we are happy to help.
What support is available if my cells behave differently than expected?
Media City Scientific provides technical support and can assist with interpretation, surface selection, and experimental optimisation within the intended research-use scope of FRS Pioneer.
Is FRS Pioneer right for you?
FRS Pioneer may be a good fit if you:
  • culture commonly used immortalised cell lines
  • want to reduce batch-to-batch variability associated with fetal bovine serum
  • prefer chemically defined, animal-free media components
  • use standard basal media and routine culture workflows
  • are comfortable handling cell adhesion separately for adherent cells
  • value reproducibility and experimental control over maximum cell density
 
FRS Pioneer may not be the right fit if you:
  • need high-density or cell type-specific optimised cell culture media
  • are working with primary cells and wish to avoid additional optimisation
Picture
Home
​
The FBS problem
Explore FRS Pioneer
Data and Application Notes
Frequently Asked Questions
Products
FRS Pioneer
GECKO
Support Services
Request a Quote
​Updates
Contact
About
© Media City Scientific
  • Explore
    • The FBS problem
    • Explore FRS Pioneer
  • Products
    • FRS Pioneer
    • GECKO
    • Support Services
  • Resources
    • Data & Application Notes
    • Frequently asked questions
  • Connect
    • Request a Quote
    • Contact
    • Updates
  • About